-
The third in a series of panel discussions will provide up-to-date information on COVID-19 from UAB experts.
-
COVID-19 vaccines will be available through the JCDH at UAB’s first home football game.
-
Pictured above: Pulmonary faculty Drs. Joseph Thachuthara-George, Aline Zouk and Hitesh Batra demonstrate the ION equipment. Hitesh Batra, M.D., MBA (Associate Professor, Pulmonary, Allergy and Critical Care) performed the first robotic-assisted bronchoscopy using the Ion™ system in the state of Alabama on August 25. This new technology from Intuitive enables minimally invasive biopsy procedures to diagnose lung cancer. The system features an ultra-thin, ultra-maneuverable catheter that allows more precise navigation inside the lung, as well as offering added stabilization for the physician performing the procedure. Congrats to the entire team for implementing this exciting advance in interventional pulmonology!
-
Videoconferencing software has helped address lower treatment rates and higher numbers of overdoses during the pandemic, but it has also made it easier for family members to stay connected to their loved one’s recovery journey.
-
Learn what you need to do if you have been exposed to COVID-19.
-
To schedule an appointment, visit UABMedicineVaccine.org, or call 205-975-1881 for assistance.
-
This finding upends the long-held paradigm that priming during lung infections takes place only in the draining lymph nodes, and it will be key to developing more efficient vaccinations and therapies for respiratory challenges.
-
September is Prostate Cancer Awareness Month and the Office of Community Outreach and Engagement at the O’Neal Comprehensive Cancer Center at UAB is working with survivors to raise awareness about the importance of screening. Three men are sharing their personal experience with screening, diagnosis, and treatment, how this disease impacted their family and friends, and life as a cancer survivor. UAB experts are concerned that the pandemic may have interrupted regularly scheduled health care. They urge patients to reach out to health care providers about age-appropriate cancer screening.
-
Above: Kelly Godby, MD, Associate Professor in the Division of Hematology and Oncology Kelly Godby, MD, has been named Interim Director for the Division of Hematology and Oncology in the UAB School of Medicine. As Interim Director, Godby will take the reigns from outgoing Division Director Ravi Bhatia, MD, who will continue to provide leadership of division research programs, serving as Interim Director for Research. Godby will work closely with Bhatia, Division Administrator Will Callans, DOM leaders, and leaders of the O'Neal Comprehensive Cancer Center and Cancer Service Line to provide stable, collaborative leadership while we complete the national search[…]
-
Above: Erin Snyder, MD, Associate Professor in the Division of General Internal Medicine Erin Snyder, MD, will serve as the first Physician Director for Ambulatory Care in the Department of Medicine. In this new role, Snyder will work with Vice Chair for Clinical Programs, Elizabeth Turnipseed, MD, and stakeholders across the enterprise to improve access to care for our patients, to enhance use of our ambulatory clinics, and to increase ambulatory practice revenue relative to costs. Snyder is Associate Professor of Medicine in the Division of General Internal Medicine and Assistant Program Director for the Tinsley Harrison Internal Medicine Residency[…]
-
Above: Timmy Lee, MD, Professor in the Division of Nephrology Timmy Lee, M.D., will serve as the next Vice Chair for Research in the Department of Medicine. In this role, Dr. Lee will build the culture of inquiry in the department and grow high-impact research across all divisions. Dr. Lee is Professor of Medicine in the Division of Nephrology and Section Chief of Nephrology at the Birmingham Veterans Affairs Medical Center. He serves as the Associate Nephrology Fellowship Director of Research, Associate Director of the Nephrology Research Training Center, and Associate Director of the UAB Kidney Undergraduate Research Experience (KURE)[…]
-
Above: Kevin Schwalbach, M.D., Chief Medical Resident (2020-2021) After Kevin Schwalbach, M.D., received his Bachelor of Science from DePaul University in Minnesota, he was unsure of where his love for science would lead him. He spent the next four years in basic science, studying the development of zebrafish and stickleback fish. Though he enjoyed the research, he realized collaboration and connection were missing from his career. It became clear to Schwalbach that all roads led to medicine. So Schwalbach enrolled in the University of Minnesota Medical School. When it was time to consider where he would complete residency after graduation, he[…]
-
Fear and self-loathing play a role in conditions from cancer to HIV and COVID-19, spurring a flood of new NIH funding for stigma research. This summer, UAB researchers led — and participated in — a first-of-its-kind “crash course” to bring more investigators into the field.
-
Three Black men from Alabama and Mississippi share the importance of prostate cancer screenings for early detection and treatment.
-
Two UAB researchers — a SARS-CoV-2 expert and a vaccine researcher — discuss the prospects for future mutations.
-
Third-year medical student Abigail Kraus was recently awarded the 2021 AOA Carolyn L. Kuckein Student Research Fellowship. The award will provide her a $5,000 stipend to support her while she conducts her research project titled “Defining the role of endothelin-1 in hyperoxia-induced kidney damage.”
-
The John B. Barnwell Award for outstanding achievement in clinical science research is the highest honor of the VA’s Clinical Science Research and Development Service.
-
UAB public health expert: Masking in Alabama during the Labor Day weekend could prevent at least 3,500 and as many as 6,000 COVID-19 cases in Alabama the following week and help end the surge.
-
The fourth in a series of panel discussions will provide up-to-date information on COVID-19 from UAB experts.
-
The dominance of the Delta strain of COVID-19 combined with Alabama’s low vaccination rate has led experts to turn to monoclonal antibody infusion, a treatment in which infected individuals are administered supplemental antibodies that aid in clearing and stopping infection. The infusion reduces the risk of hospitalization by 70 percent in high-risk unvaccinated and pregnant persons. Experts emphasize getting vaccinated remains the most effective way to reduce hospitalizations and stop the spread of COVID-19.
